Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRICE 2: A Phase 3 Randomized Controlled Trial of Phlebotomy Resulting in Controlled Hypovolemia to Prevent Blood Loss in Major Hepatic Resections

NCT03651154 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.

NCT NCT03651154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03651154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRICE 2: A Phase 3 Randomized Controlled Trial of Phlebotomy Resulting in Controlled Hypovolemia to Prevent Blood Loss in Major Hepatic Resections
Lead sponsor
Ottawa Hospital Research Institute
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 28, 2018
Completion date
January 31, 2026
Enrollment
440 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

blood loss, surgical, blood transfusion, hepatectomy, liver neoplasms